艾滋病毒的诊断会给患者带来从感染到肿瘤等二次医疗风险。关于皮肤癌，这些风险超出了众所周知的卡波西肉瘤的范围，还包括默克尔细胞癌、鳞状细胞癌和高风险黑色素瘤。尽管有证据表明存在这些风险，但艾滋病毒感染者的护理人员、个体患者、甚至一些皮肤科专家的知识和认识仍然很低。至关重要的是，医疗组织没有充分解决这一问题，因为缺乏针对艾滋病毒感染者的皮肤癌筛查和管理的治疗指南。为了继续为这一人群提供高质量的护理，提供者和患者都需要适当认识到多种高危皮肤癌的风险增加。因此，我们呼吁重新重视患者教育并实施改进的皮肤癌筛查方案组织指南。版权所有 © 2023 Elsevier Ltd。保留所有权利。

A diagnosis of HIV poses secondary medical risks to patients, ranging from infections to neoplastic conditions. Regarding skin cancer, these risks extend beyond the well known association with Kaposi sarcoma and include Merkel cell carcinoma, squamous cell carcinoma, and high-risk melanomas. Despite evidence of these risks, knowledge and awareness remain low, among care providers for people living with HIV, individual patients, and even some specialists in dermatology. Crucially, medical organisations do not adequately address this concern, as there is an absence of treatment guidelines for the screening and management of skin cancer for people living with HIV. To continue providing high-quality care for this population, the increased risk of multiple high-risk skin cancers needs to be appropriately recognised by both providers and patients. Accordingly, we call for renewed emphasis on patient education and implementation of improved organisational guidelines for skin cancer screening protocols.Copyright © 2023 Elsevier Ltd. All rights reserved.